Asia Pacific Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
Asia Pacific mrna therapeutics contract development & manufacturing market, 2021-2030 (US$M)
Related Markets
Asia Pacific mrna therapeutics contract development & manufacturing market highlights
- The Asia Pacific mrna therapeutics contract development & manufacturing market generated a revenue of USD 1,015.1 million in 2023.
- The market is expected to grow at a CAGR of 10% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating indication in 2023.
- Infectious Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,015.1 million |
| Market revenue in 2030 | USD 1,979.5 million |
| Growth rate | 10% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Infectious Diseases |
| Historical data covered | 2021 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases |
| Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.5% of the global mrna therapeutics contract development & manufacturing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 3,228.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The mRNA therapeutics contract development & manufacturing organization (CDMO) market in Asia Pacific has witnessed significant growth and promising developments in recent years. Some key factors contributing to this growth are increasing R&D investments, rising prevalence of diseases that can be targeted by mRNA therapies, and advancements in technology.
As per a survey-based study sponsored and published by Merck KGaA in May 2023, mRNA technology is expected to be a “game-changer” for vaccine manufacturers in Asia Pacific. Around 87% of survey respondents, comprising vaccine manufacturers across APAC, deemed mRNA a promising technology owing to governments investing and supporting therapeutic discovery & manufacturing in the sector.
mRNA is anticipated to be a key modality in the future due to benefits such as shorter development time, flexibility in covering different types of diseases & variants, templated manufacturing processes, and lower biohazard risk for operators. The study identified Japan, Singapore, Australia, Indonesia, China, South Korea, and India as key markets actively exploring the development of mRNA technology.
Reasons to subscribe to Asia Pacific mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific mrna therapeutics contract development & manufacturing market size, by country, 2021-2030 (US$M)
Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
